{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:42:03Z","timestamp":1791236523493,"version":"4.1.0"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Gastroenterology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.bpg.2025.101990","type":"journal-article","created":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T12:45:44Z","timestamp":1738845944000},"page":"101990","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Treatment targets in IBD: is it time for new strategies?"],"prefix":"10.1016","volume":"77","author":[{"given":"Fabrizio","family":"Fanizzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdinando","family":"D'Amico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Peyrin-Biroulet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvio","family":"Danese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Dignass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpg.2025.101990_bib1","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1053\/j.gastro.2020.12.031","article-title":"STRIDE-II: an update on the selecting therapeutic targets in inflammatory bowel disease (STRIDE) initiative of the International Organization for the study of IBD (IOIBD): Determining therapeutic goals for treat-to-target strategies in IBD","volume":"160","author":"Turner","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2025.101990_bib2","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/ajg.2015.233","article-title":"Selecting therapeutic targets in inflammatory bowel disease (STRIDE): Determining therapeutic goals for treat-to-target","volume":"110","author":"Peyrin-Biroulet","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2025.101990_bib3","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/apt.17622","article-title":"Review article: Translating STRIDE\u2010II into clinical reality \u2013 opportunities and challenges","volume":"58","author":"Dignass","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.bpg.2025.101990_bib4","doi-asserted-by":"crossref","first-page":"455","DOI":"10.5009\/gnl16308","article-title":"Inflammatory bowel disease: updates on molecular targets for biologics","volume":"11","author":"Katsanos","year":"2017","journal-title":"Gut Liver"},{"issue":"7","key":"10.1016\/j.bpg.2025.101990_bib5","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.cgh.2018.12.021","article-title":"Clinical parameters correlate with endoscopic activity of ulcerative colitis: a systematic review","volume":"17","author":"Restellini","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2025.101990_bib6","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.cgh.2014.07.055","article-title":"A Panel to predict long-term outcome of infliximab therapy for patients with ulcerative colitis","volume":"13","author":"Arias","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2025.101990_bib7","doi-asserted-by":"crossref","DOI":"10.14309\/ajg.0000000000002404","article-title":"Bowel urgency in ulcerative colitis: current perspectives and future Directions","author":"Dubinsky","year":"2023","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2025.101990_bib8","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1093\/ibd\/izad142","article-title":"The Communicating needs and Features of IBD Experiences (CONFIDE) study: US and European patient and health care Professional perceptions of the experience and impact of symptoms of moderate-to-severe ulcerative colitis","volume":"30","author":"Travis","year":"2024","journal-title":"Inflamm Bowel Dis"},{"issue":"5","key":"10.1016\/j.bpg.2025.101990_bib9","article-title":"Clinical effect of Mirikizumab treatment on bowel urgency in patients with moderately to severely active ulcerative colitis and the clinical relevance of bowel urgency improvement for disease remission","volume":"360","author":"Dubinsky","year":"2023","journal-title":"Crohns Colitis"},{"key":"10.1016\/j.bpg.2025.101990_bib10","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1053\/j.gastro.2015.07.003","article-title":"Biomarkers of inflammation in inflammatory bowel disease","volume":"149","author":"Sands","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2025.101990_bib11","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/2136501","article-title":"Systematic review with meta-analysis: fecal calprotectin as a surrogate marker for predicting relapse in adults with ulcerative colitis","volume":"2019","author":"Li","year":"2019","journal-title":"Mediat Inflamm"},{"key":"10.1016\/j.bpg.2025.101990_bib12","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/ueg2.12069","article-title":"International consensus on methodological issues in standardization of fecal calprotectin measurement in inflammatory bowel diseases","volume":"9","author":"D'Amico","year":"2021","journal-title":"United Eur Gastroenterol J"},{"key":"10.1016\/j.bpg.2025.101990_bib13","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1093\/ibd\/izac230","article-title":"Leucine-rich alpha-2 Glycoprotein is a reliable serum biomarker for evaluating clinical and endoscopic disease activity in inflammatory bowel disease","volume":"29","author":"Shimoyama","year":"2023","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.bpg.2025.101990_bib14","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1093\/ecco-jcc\/jjx103","article-title":"Endoscopic and histological mucosal healing in ulcerative colitis in the first Year of diagnosis: results from a population-based Inception cohort from Six Countries in Asia","volume":"11","author":"Leung","year":"2017","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.bpg.2025.101990_bib15","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1111\/apt.12289","article-title":"Impact of mucosal healing on long\u2010term outcomes in ulcerative colitis treated with infliximab: a multicenter experience","volume":"37","author":"Laharie","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bpg.2025.101990_bib16","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.3390\/biomedicines11082139","article-title":"New technologies in Digestive endoscopy for ulcerative colitis patients","volume":"11","author":"Biamonte","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.bpg.2025.101990_bib17","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.cgh.2013.02.030","article-title":"Histologic markers of inflammation in patients with ulcerative colitis in clinical remission","volume":"11","author":"Rosenberg","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2025.101990_bib18","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/j.cgh.2020.09.046","article-title":"Treat to target: the role of histologic healing in inflammatory bowel diseases: a systematic review and meta-analysis","volume":"19","author":"Gupta","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2025.101990_bib19","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.cgh.2013.06.023","article-title":"Inflammation is an independent risk factor for colonic neoplasia in patients with ulcerative colitis: a Case\u2013control study","volume":"11","author":"Rubin","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2025.101990_bib20","doi-asserted-by":"crossref","first-page":"179","DOI":"10.14309\/ajg.0000000000000437","article-title":"Histological remission in ulcerative colitis: under the microscope is the cure","volume":"115","author":"Chateau","year":"2020","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.bpg.2025.101990_bib21","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/jcag\/gwad034","article-title":"Managing ulcerative colitis and Crohn's disease: should the target Be endoscopy, histology, or both?","volume":"7","author":"Magro","year":"2023","journal-title":"J Can Assoc Gastroenterol."},{"key":"10.1016\/j.bpg.2025.101990_bib22","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1093\/ecco-jcc\/jjaa110","article-title":"ECCO Position Paper: Harmonization of the approach to ulcerative colitis histopathology","volume":"14","author":"Magro","year":"2020","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.bpg.2025.101990_bib23","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/S2468-1253(24)00053-0","article-title":"Artificial intelligence and endo-histo-omics: new dimensions of precision endoscopy and histology in inflammatory bowel disease","volume":"9","author":"Iacucci","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2025.101990_bib24","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/ueg2.12288","article-title":"Ulcerative colitis: impact of early disease clearance on long\u2010term outcomes \u2010 A multicenter cohort study","volume":"10","author":"D'Amico","year":"2022","journal-title":"United Eur Gastroenterol J"},{"key":"10.1016\/j.bpg.2025.101990_bib25","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.3748\/wjg.v30.i13.1801","article-title":"Disease clearance in ulcerative colitis: a new therapeutic target for the future","volume":"30","author":"Hassan","year":"2024","journal-title":"World J Gastroenterol"},{"issue":"5","key":"10.1016\/j.bpg.2025.101990_bib26","first-page":"233","article-title":"Disease clearance in inflammatory bowel disease","volume":"17","author":"Colombel","year":"2021","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2025.101990_bib27","doi-asserted-by":"crossref","first-page":"i92","DOI":"10.1093\/ecco-jcc\/jjad212.0051","article-title":"DOP11 Disease clearance after 16 weeks of treatment with vedolizumab in patients with moderate to severe Ulcerative Colitis: an interim analysis from the VERDICT trial","volume":"18","author":"Jairath","year":"2024","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.bpg.2025.101990_bib28","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/ueg2.12436","article-title":"Disease clearance in ulcerative colitis: is the ultimate therapeutic target?","volume":"11","author":"D'Amico","year":"2023","journal-title":"United Eur Gastroenterol J"},{"key":"10.1016\/j.bpg.2025.101990_bib29","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/ecco-jcc\/jjz163","article-title":"Systematic review: clinical utility of gastrointestinal ultrasound in the diagnosis, assessment and management of patients with ulcerative colitis","volume":"14","author":"Smith","year":"2020","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.bpg.2025.101990_bib30","doi-asserted-by":"crossref","first-page":"E1116","DOI":"10.1055\/a-1481-8032","article-title":"Reliability of the Endoscopic Ultrasound Ulcerative Colitis (EUS-UC) score for assessment of inflammation in patients with ulcerative colitis","volume":"9","author":"Yan","year":"2021","journal-title":"Endosc Int Open"},{"key":"10.1016\/j.bpg.2025.101990_bib31","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.dld.2019.10.004","article-title":"Impact of intestinal ultrasound on the management of patients with inflammatory bowel disease: how to apply scientific evidence to clinical practice","volume":"52","author":"Fraquelli","year":"2020","journal-title":"Dig Liver Dis"},{"issue":"6","key":"10.1016\/j.bpg.2025.101990_bib32","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1053\/j.gastro.2022.10.005","article-title":"The Use of intestinal ultrasound in ulcerative colitis-more than a mucosal disease?","volume":"163","author":"Palmela","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2025.101990_bib33","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1111\/apt.15767","article-title":"Transperineal ultrasound predicts endoscopic and histological healing in ulcerative colitis","volume":"51","author":"Sagami","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.bpg.2025.101990_bib34","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/ueg2.12206","article-title":"Predictive value of Milan ultrasound criteria in ulcerative colitis: a prospective observational cohort study","volume":"10","author":"Allocca","year":"2022","journal-title":"United European Gastroenterol J"},{"issue":"4","key":"10.1016\/j.bpg.2025.101990_bib35","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1177\/2050640620980203","article-title":"Milan ultrasound criteria are accurate in assessing disease activity in ulcerative colitis: external validation","volume":"9","author":"Allocca","year":"2021","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.bpg.2025.101990_bib36","doi-asserted-by":"crossref","DOI":"10.1093\/ecco-jcc\/jjac190.0367","article-title":"Superior predictive value of transmural over endoscopic severity for colectomy risk in ulcerative colitis: a multicentre prospective cohort study","author":"Piazza","year":"2023","journal-title":"J Crohns Colitis"},{"issue":"4","key":"10.1016\/j.bpg.2025.101990_bib37","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/01.MIB.0000215091.77492.2a","article-title":"Predicting the Crohn's disease activity index from the Harvey-Bradshaw Index","volume":"12","author":"Best","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.bpg.2025.101990_bib38","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/gutjnl-2013-304984","article-title":"Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial","volume":"63","author":"Peyrin-Biroulet","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2025.101990_bib39","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1016\/S0140-6736(17)32641-7","article-title":"Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial","volume":"390","author":"Colombel","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2025.101990_bib40","doi-asserted-by":"crossref","DOI":"10.2169\/internalmedicine.53.2627","article-title":"Slight increases in the disease activity index and Platelet Count imply the presence of active intestinal Lesions in C-reactive protein-negative Crohn's disease patients","author":"Nakarai","year":"2014","journal-title":"Intern Med"},{"key":"10.1016\/j.bpg.2025.101990_bib41","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1097\/MIB.0000000000001202","article-title":"Fecal calprotectin more accurately predicts endoscopic remission of Crohn\u02bcs disease than serological biomarkers evaluated using Balloon-assisted enteroscopy","volume":"23","author":"Kawashima","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.bpg.2025.101990_bib42","article-title":"Does fecal calprotectin predict short-term relapse after stopping TNF\u03b1-blocking agents in inflammatory bowel disease patients in deep remission?","volume":"S1873994614002098","author":"Molander","year":"2014","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.bpg.2025.101990_bib43","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1097\/MIB.0000000000001082","article-title":"Clinical utility of fecal calprotectin monitoring in asymptomatic patients with inflammatory bowel disease: a systematic review and practical guide","volume":"23","author":"Heida","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.bpg.2025.101990_bib44","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.dld.2014.07.013","article-title":"Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor \u03b1 agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year","volume":"46","author":"Guidi","year":"2014","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.bpg.2025.101990_bib45","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.3748\/wjg.v25.i19.2354","article-title":"Combined evaluation of biomarkers as predictor of maintained remission in Crohn's disease","volume":"25","author":"Sollelis","year":"2019","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.bpg.2025.101990_bib46","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/apt.13276","article-title":"Systematic review: factors associated with relapse of inflammatory bowel disease after discontinuation of anti\u2010 TNF therapy","volume":"42","author":"Gisbert","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.bpg.2025.101990_bib47","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.cgh.2008.06.010","article-title":"Relationships between disease activity and serum and fecal biomarkers in patients with Crohn's disease","volume":"6","author":"Jones","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2025.101990_bib48","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/apt.13475","article-title":"Systematic review with meta\u2010analysis: mucosal healing is associated with improved long\u2010term outcomes in Crohn's disease","volume":"43","author":"Shah","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bpg.2025.101990_bib49","doi-asserted-by":"crossref","first-page":"S330","DOI":"10.14309\/00000434-201810001-00574","article-title":"Early endoscopic evaluation after initiation of biologic therapy reduces disease-related complications in inflammatory bowel disease, supporting the Concept of treat-to-target: 574","volume":"113","author":"Limketkai","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2025.101990_bib50","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1148\/radiol.2018171737","article-title":"Consensus recommendations for evaluation, Interpretation, and Utilization of computed tomography and magnetic resonance enterography in patients with small bowel Crohn's disease","volume":"286","author":"Bruining","year":"2018","journal-title":"Radiology"},{"key":"10.1016\/j.bpg.2025.101990_bib51","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1185\/030079905X65457","article-title":"Endoscopic and histologic evidence of persistent mucosal healing and correlation with clinical improvement following sustained infliximab treatment for Crohn's disease","volume":"21","author":"Geboes","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.bpg.2025.101990_bib52","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ejim.2014.02.010","article-title":"Effectiveness and safety of infliximab and adalimumab for ambulatory Crohn's disease patients in primary gastroenterology centres","volume":"25","author":"Tursi","year":"2014","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.bpg.2025.101990_bib53","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/ecco-jcc\/jjac006","article-title":"ECCO Position on Harmonisation of Crohn's disease mucosal histopathology","volume":"16","author":"Magro","year":"2022","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.bpg.2025.101990_bib54","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/1751-2980.12937","article-title":"Histological scores in inflammatory bowel disease","volume":"22","author":"Neri","year":"2021","journal-title":"J Dig Dis"},{"key":"10.1016\/j.bpg.2025.101990_bib55","article-title":"Can Magnetic Resonance Enterography (MRE) replace ileo-colonoscopy for evaluating disease activity in Crohn's disease?","volume":"38\u201339","author":"Varyani","year":"2019","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.bpg.2025.101990_bib56","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.cgh.2018.01.024","article-title":"Associations Among mucosal and transmural healing and fecal level of calprotectin in Children with Crohn's disease","volume":"16","author":"Weinstein-Nakar","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.bpg.2025.101990_bib57","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/apt.15190","article-title":"One-year clinical outcomes with biologics in Crohn's disease: transmural healing compared with mucosal or no healing","volume":"49","author":"Castiglione","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bpg.2025.101990_bib58","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S2468-1253(21)00096-0","article-title":"Transmural healing as a therapeutic goal in Crohn's disease: a systematic review","volume":"6","author":"Geyl","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2025.101990_bib59","doi-asserted-by":"crossref","DOI":"10.2169\/internalmedicine.9066-21","article-title":"The evaluation of transmural healing by low-dose computed tomography enterography in patients with Crohn's disease","author":"Fujimura","year":"2022","journal-title":"Intern Med"},{"key":"10.1016\/j.bpg.2025.101990_bib60","article-title":"Combined endoscopic and radiologic healing is associated with a better prognosis than endoscopic healing only in patients with Crohn's disease receiving anti-TNF therapy","volume":"13","author":"Oh","year":"2022","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.bpg.2025.101990_bib61","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/ecco-jcc\/jjae042","article-title":"Magnetic resonance enterography and intestinal ultrasound for the assessment and monitoring of Crohn's disease","volume":"18","author":"Kumar","year":"2024","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.bpg.2025.101990_bib62","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1097\/MIB.0000000000000727","article-title":"Medical imaging in small bowel Crohn\u02bcs disease\u2014Computer tomography enterography, magnetic resonance enterography, and ultrasound: \u201cwhich one is the best for what?","volume":"22","author":"Greenup","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.bpg.2025.101990_bib63","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.3390\/diagnostics14151639","article-title":"Role of intestinal ultrasound for IBD care: a practical approach","volume":"14","author":"Hoffmann","year":"2024","journal-title":"Diagnostics"},{"issue":"Issue Supplement_1","key":"10.1016\/j.bpg.2025.101990_bib64","doi-asserted-by":"crossref","first-page":"i837","DOI":"10.1093\/ecco-jcc\/jjac190.0836","article-title":"P706 Monitoring asymptomatic patients with Crohn's disease: the role of intestinal ultrasound","volume":"17","author":"Dussias","year":"2023","journal-title":"Journal of Crohn's and Colitis"},{"key":"10.1016\/j.bpg.2025.101990_bib65","doi-asserted-by":"crossref","first-page":"i304","DOI":"10.1093\/ecco-jcc\/jjad212.0172","article-title":"P042 Significant correlation between intestinal ultrasound and magnetic resonance enterography for assessing disease activity and complications in Crohn's disease","volume":"18","author":"B\u00e1rbara","year":"2024","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.bpg.2025.101990_bib66","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.dld.2023.10.016","article-title":"Inflammatory mesenteric fat detected by Intestinal ultrasound is correlated with poor long-term clinical outcomes in patients with Crohn's disease","volume":"56","author":"Cheng","year":"2024","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.bpg.2025.101990_bib67","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s43162-024-00316-6","article-title":"The intestinal ultrasound role in inflammatory bowel disease in clinical practice and a critical appraisal of the current guidelines (mini-review)","volume":"36","author":"El-Nakeep","year":"2024","journal-title":"Egypt J Intern Med"},{"key":"10.1016\/j.bpg.2025.101990_bib68","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1097\/00042737-200510000-00006","article-title":"Course of disease, drug treatment and health-related quality of life in patients with inflammatory bowel disease 5 years after initial diagnosis","volume":"17","author":"Bernklev","year":"2005","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.bpg.2025.101990_bib69","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1177\/1359105312459094","article-title":"The importance of illness perceptions, quality of life and psychological status in patients with ulcerative colitis and Crohn's disease","volume":"18","author":"Rochelle","year":"2013","journal-title":"J Health Psychol"},{"key":"10.1016\/j.bpg.2025.101990_bib70","doi-asserted-by":"crossref","first-page":"455","DOI":"10.5009\/gnl16308","article-title":"Inflammatory bowel disease: updates on molecular targets for biologics","volume":"11","author":"Katsanos","year":"2017","journal-title":"Gut Liver"},{"key":"10.1016\/j.bpg.2025.101990_bib71","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.2741\/s324","article-title":"Inflammatory bowel diseases emerging therapies and promising molecular targets","volume":"S4","author":"Mannon","year":"2012","journal-title":"Front Biosci"},{"key":"10.1016\/j.bpg.2025.101990_bib72","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.gtc.2014.05.003","article-title":"Immunology of inflammatory bowel disease and molecular targets for biologics","volume":"43","author":"Dave","year":"2014","journal-title":"Gastroenterol Clin North Am"},{"issue":"1","key":"10.1016\/j.bpg.2025.101990_bib73","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S2468-1253(21)00299-5","article-title":"The Crohn's disease exclusion diet for induction and maintenance of remission in adults with mild-to-moderate Crohn's disease (CDED-AD): an open-label, pilot, randomised trial","volume":"7","author":"Yanai","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2025.101990_bib74","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.yasu.2024.04.002","article-title":"Management of complications in Crohn's disease","volume":"58","author":"Carroll","year":"2024","journal-title":"Adv Surg"},{"key":"10.1016\/j.bpg.2025.101990_bib75","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3748\/wjg.v30.i1.50","article-title":"Treat to target in Crohn's disease: a practical guide for clinicians","volume":"30","author":"Srinivasan","year":"2024","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.bpg.2025.101990_bib76","doi-asserted-by":"crossref","first-page":"480","DOI":"10.5946\/ce.2022.108","article-title":"Endoscopic activity in inflammatory bowel disease: clinical significance and application in practice","volume":"55","author":"Kim","year":"2022","journal-title":"Clin Endosc"},{"key":"10.1016\/j.bpg.2025.101990_bib77","doi-asserted-by":"crossref","first-page":"6292","DOI":"10.3390\/jcm12196292","article-title":"Benefits and challenges of treat-to-target in inflammatory bowel disease","volume":"12","author":"West","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.bpg.2025.101990_bib78","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3390\/jcm13010289","article-title":"Considering histologic remission in ulcerative colitis as a long-term target","volume":"13","author":"Pavel","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.bpg.2025.101990_bib79","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.3390\/biomedicines12071520","article-title":"Precision medicine in inflammatory bowel disease: a Spotlight on emerging molecular biomarkers","volume":"12","author":"Mestrovic","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.bpg.2025.101990_bib80","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1097\/MIB.0000000000000836","article-title":"Emerging biomarkers for the diagnosis and monitoring of inflammatory bowel diseases","volume":"22","author":"Soubi\u00e8res","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.bpg.2025.101990_bib81","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s40291-017-0298-4","article-title":"Recent advances in the Etiopathogenesis of inflammatory bowel disease: the role of omics","volume":"22","author":"Stylianou","year":"2018","journal-title":"Mol Diagn Ther"},{"key":"10.1016\/j.bpg.2025.101990_bib82","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1038\/s41598-024-53522-1","article-title":"Longitudinal assessment of sweat-based TNF-alpha in inflammatory bowel disease using a wearable device","volume":"14","author":"Hirten","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.bpg.2025.101990_bib83","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1093\/ibd\/izad159","article-title":"Disease clearance as a new outcome in ulcerative colitis: a systematic review and Expert consensus","volume":"30","author":"D'Amico","year":"2024","journal-title":"Inflamm Bowel Dis"}],"container-title":["Best Practice & Research Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691825000174?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691825000174?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T07:37:45Z","timestamp":1754293065000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521691825000174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":83,"alternative-id":["S1521691825000174"],"URL":"https:\/\/doi.org\/10.1016\/j.bpg.2025.101990","relation":{},"ISSN":["1521-6918"],"issn-type":[{"value":"1521-6918","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment targets in IBD: is it time for new strategies?","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpg.2025.101990","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101990"}}